首页> 中文期刊> 《中国继续医学教育》 >支气管哮喘合并结核感染儿童的临床治疗研究

支气管哮喘合并结核感染儿童的临床治疗研究

         

摘要

Objective To analysis the research on clinical treatment of children bronchial asthma and tuberculosis.Methods Selected 26 children tuberculous infection combined with bronchial asthma from March 2013 to September 2013 as the research group, and selected another 26 children that not combining tuberculous infection of bronchial asthma of the same time as control group. Both of them accepted the inhalation therapy of budesonide formoterol, but the research group additionally used the antituberculosis drugs as adjuvant treatment. Then contrasted and observed the drug dosage, respiratory infection and times of hospitalization of the two groups.Results Compared with the control group, the drug dosage used by the children of the research group was lower, and their respiratory tract infection as well as the emergent times was less after the treatment,P<0.05, was difference had statistically significance.Conclusion Tuberculosis can improve the curative effect of children with bronchial asthma using glucocorticoid inhalation, Prevention and treatment of bronchial asthma clinical response further study.%目的 研究支气管哮喘合并结核感染儿童的临床治疗方法 .方法 将我院2013年3月~2013年9月接诊的26例合并结核感染的支气管哮喘儿作为研究对象,另选取同期26例未合并结核感染的支气管哮喘患儿作为对照组.均行布地奈德福莫特罗吸入治疗,研究组另使用抗结核药物辅助治疗.对比两组患儿治疗期间用药剂量、呼吸道感染以及住院次数.结果 研究组住院期间药物使用剂量低于对照组,治疗后研究组呼吸道感染次数与急诊次数更少,P<0.05,差异具有统计学意义.结论 结核感染能改善支气管哮喘患儿使用糖皮质激素吸入的疗效,临床应对支气管哮喘的防治进一步深入研究.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号